ADIAL Pharma files complex 8-K with 8 items and nested disclosures

Yesterday's SEC filings (290 8-Ks, 13 424B5s, 3 S-3s) were dominated by event-driven disclosures in pharma and acquisition vehicles.

Top 3

• ADIAL PHARMACEUTICALS filed an 8-K with 8 item codes (1.01, 2.01, 2.03, 3.02, 5.02, 5.03, 7.01, 9.01), scoring 300 for complexity; buried item 1.01 references suggest material event nested under cost-associated disclosures.
• Vireo Growth Inc. reported an 8-K with 5 items (1.01, 2.03, 3.02, 7.01, 9.01), likely signaling a material agreement or acquisition; item 1.01 buries item 2.01 (cost-related detail).
• Spark I Acquisition Corp filed a 4-item 8-K (1.01, 3.02, 7.01, 9.01), consistent with SPAC activity; item 7.01 buried under item 1.01 suggests regulatory or transactional detail.

Paid subscribers see 7 more flagged filings + sector signals — upgrade for $9/mo: https://filingfirehose.com/daily/upgrade

FilingFirehose Daily · 2026-06-12